Artículos por temáticas

Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training

Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM.

J Alzheimers Dis. 2019;69(2):401-411. doi: 10.3233/JAD-180952.

Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease

Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S.

J Alzheimers Dis. 2019;72(4):1313-1322. doi: 10.3233/JAD-190791.

ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker

Manzine PR, Ettcheto M, Cano A, Busquets O, Marcello E, Pelucchi S, Di Luca M, Endres K, Olloquequi J, Camins A, Cominetti MR.

Biomed Pharmacother. 2019 May;113:108661. doi: 10.1016/j.biopha.2019.108661. Epub 2019 Mar 2.

Predictor Factors of Perceived Health in Family Caregivers of People Diagnosed with Mild or Moderate Alzheimer's Disease

Ruiz-Fernández MD, Hernández-Padilla JM, Ortiz-Amo R, Fernández-Sola C, Fernández-Medina IM, Granero-Molina J.

Int J Environ Res Public Health. 2019 Oct 7;16(19):3762. doi: 10.3390/ijerph16193762.

Measuring Effects of Nondrug Interventions on Behaviors: Music & Memory Pilot Study

McCreedy EM, Yang X, Baier RR, Rudolph JL, Thomas KS, Mor V.

J Am Geriatr Soc. 2019 Oct;67(10):2134-2138. doi: 10.1111/jgs.16069. Epub 2019 Jul 13.

Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial

Maltais M, de Souto Barreto P, Pothier K, Cantet C, Andrieu S, Rolland Y, Vellas B; MAPT/DSA Study Group.

Exp Gerontol. 2019 Jun;120:28-34. doi: 10.1016/j.exger.2019.02.010. Epub 2019 Feb 26.

Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial

Forlenza OV, Radanovic M, Talib LL, Gattaz WF.

Br J Psychiatry. 2019 Nov;215(5):668-674. doi: 10.1192/bjp.2019.76.

Utilization, effect, and benefit of the individualized Meeting Centers Support Program for people with dementia and caregivers

Dröes RM, van Rijn A, Rus E, Dacier S, Meiland F.

Clin Interv Aging. 2019 Aug 26;14:1527-1553. doi: 10.2147/CIA.S212852. eCollection 2019.

Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial

Vila-Castelar C, Ly JJ, Kaplan L, Van Dyk K, Berger JT, Macina LO, Stewart JL, Foldi NS.

Arch Clin Neuropsychol. 2019 May 1;34(3):277-289. doi: 10.1093/arclin/acy032.

Why Not a Global Postural Reeducation as an Alternative Therapy Applied to Alzheimer's Patients in Nursing Homes? A Pioneer Randomized Controlled Trial

Todri J, Todri A, Lena O.

Dement Geriatr Cogn Disord. 2019;48(3-4):172-179. doi: 10.1159/000505397. Epub 2020 Jan 31.

Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report

Salehpour F, Hamblin MR, DiDuro JO.

Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):159-167. doi: 10.1089/photob.2018.4569.

Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.

Br J Clin Pharmacol. 2019 Jan;85(1):71-99. doi: 10.1111/bcp.13734. Epub 2018 Oct 17.

Can Adults with Mild Cognitive Impairment Build Cognitive Reserve and Learn Mindfulness Meditation? Qualitative Theme Analyses from a Small Pilot Study

Wells RE, Kerr C, Dossett ML, Danhauer SC, Sohl SJ, Sachs BC, Feeley JW, Wolkin J, Wall R, Kaptchuk T, Press DZ, Phillips RS, Yeh GY.

J Alzheimers Dis. 2019;70(3):825-842. doi: 10.3233/JAD-190191.

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study

Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y.

J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148.

[Exploring Therapeutic Targets for Alzheimer's Disease by Comprehensive Genetic Analysis]

Ikeuchi T.

Brain Nerve. 2019 Oct;71(10):1081-1088. doi: 10.11477/mf.1416201407.